Replication of murine coronavirus defective interfering RNA from negative-strand transcripts

Journal of Virology

Volumn 70, Issue 9, 1996, Pages 5769-5776

  Joo, Myungsoo ^a,b   Banerjee, Sangeeta ^a   Makino, Shinji ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIGNAL PEPTIDE;

ARTICLE; CORONAVIRUS; DNA FLANKING REGION; GENETIC TRANSFECTION; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA REPLICATION; RNA TRANSCRIPTION; SEQUENCE ANALYSIS; VIRUS REPLICATION;

EID: 0029843982     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.9.5769-5776.1996     Document Type: Article

References (54)

1. Ball, L. A. 1994. Replication of the genomic RNA of a positive-strand RNA animal virus from negative-sense transcripts. Proc. Natl. Acad. Sci. USA 91:12443-12447.
2. Baric, R. S., S. A. Stohlman, and M. M. C. Lai. 1983. Characterization of replicative intermediate RNA of mouse hepatitis virus: presence of leader RNA sequences on nascent chains. J. Virol. 48:633-640.
3. Bonilla, P. J., A. E. Gorbalenya, and S. R. Weiss. 1994. Mouse hepatitis virus strain A59 RNA polymerase gene ORF la: heterogeneity among MHV strains. Virology 198:736-740.
4. Chang, R.-Y., M. A. Hofmann, P. B. Sethna, and D. A. Brian. 1994. A cis-acting function for the coronavirus leader in defective interfering RNA replication. J. Virol. 68:8223-8231.
5. Chen, Z., K. S. Faaberg, and P. G. W. Plagemann. 1994. Determination of the 5′ end of the lactate dehydrogenase-elevating virus genome by two independent approaches. J. Gen. Virol. 75:925-930.
6. Collis, P. S., B. J. O'Donnell, D. J. Barton, J. A. Rogers, and J. B. Flanegan. 1992. Replication of poliovirus RNA and subgenomic RNA transcripts in transfected cells. J. Virol. 66:6480-6488.
7. de Groot, R. J., R. G. van der Most, and W. J. M. Spaan. 1992. The fitness of defective interfering murine coronavirus Dl-a and its derivatives is decreased by nonsense and frameshift mutations. J. Virol. 66:5898-5905.
8. Fosmire, J. A., K. Hwang, and S. Makino. 1992. Identification and characterization of a coronavirus packaging signal. J. Virol. 66:3522-3530.
9. Frohman, M. A., M. K. Dush, and G. R. Martin. 1988. Rapid production of full-length cDNAs from rare transcripts: amplification using a single genespecific oligonucleotide primer. Proc. Natl. Acad. Sci. USA 85:8998-9002.
10. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:8122-8126.
11. Hirano, N., K. Fujiwara, S. Hino, and M. Matsumoto. 1974. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:298-302.
12. Hiscox, J. A., K. L. Mawdilt, D. Cavanagh, and P. Brilton. 1995. Investigation of the control of coronavirus subgenomic mRNA transcription by using T7-generated negative-sense RNA transcripts. J. Virol. 69:6219-6227.
13. Hofmann, M. A., and D. A. Brian. 1991. A PCR-enhanced method for determining the 5′ end sequences of mRNAs. PCR Methods Applic. 1:43-45.
14. Jeong, Y. S., and S. Makino. 1992. Mechanism of coronavirus transcription: duration of primary transcription initiation activity and effect of subgenomic RNA transcription on RNA replication. J. Virol. 66:3339-3346.
15. Jeong, Y. S., and S. Makino. 1994. Evidence for coronavirus discontinuous transcription. J. Virol, 68:2615-2623.
16. Jeong, Y. S., J. F. Repass, Y.-N. Kim, S. M. Hwang, and S. Makino. 1996. Coronavirus transcription mediated by sequences flanking the transcription consensus sequence. Virology 217:311-322.
17. Joo, M., and S, Makino. 1992. Mutagenic analysis of the coronavirus intergenic consensus sequence. J. Virol. 66:6330-6337.
18. Joo, M., and S. Makino. 1995. The effect of two closely inserted transcription consensus sequences on coronavirus transcription. J. Virol. 69:272-280.
19. Kim, Y.-N., Y. S. Jeong, and S. Makino. 1993. Analysis of cis-acting sequences essential for coronavirus defective interfering RNA replication. Virology 197:53-63.
20. Kim, Y.-N., M. M. C. Lai, and S. Makino. 1993. Generation and selection of coronavirus defective interfering RNA with large open reading frame by RNA recombination and possible editing. Virology 194:244-253.
21. Kim, Y.-N., and S. Makino. 1995. Characterization of a murine coronavirus defective interfering RNA internal cis-acting replication signal. J. Virol. 69:4963-4971.
22. Lai, M. M. C., R. S. Baric, P. R. Brayton, and S. A. Stohlman. 1984. Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. Proc. Natl. Acad. Sci. USA 81:3626-3630.
23. Lai, M. M. C., P. R. Brayton, R. C. Armen, C. D. Patton, C. Pugh, and S. A. Stohlman. 1981. Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3. J. Virol. 39:823-834.
24. Lai, M. M. C., C. D. Patton, R. S. Baric, and S. A. Stohlman. 1983. Presence of leader sequences in the mRNA of mouse hepatitis virus. J. Virol. 46:1027-1033.
25. Lai, M. M. C., and S. A. Stohlman. 1978. RNA of mouse hepatitis virus. J. Virol. 26:236-242.
26. Lee, H.-J., C.-K. Shieh, A. E. Gorbalenya, E. V. Eugene, N. La Monica, J. Tuler, A. Bagdzhadzhyan, and M. M. C. Lai. 1991. The complete sequence (22 kilobases) of murine coronavirus gene 1 encoding the putative proteases and RNA polymerase. Virology 180:567-582.
27. Leihowitz, J. L., K. C. Wilhelmsen, and C. W. Bond. 1981. The virus-specific intracellular RNA species of two murine coronaviruses: MHV-A59 and MHV-JHM. Virology 114:39-51.
28. Liao, C.-L., and M. M. C. Lai. 1995. A cis-acting viral protein is not required for the replication of a coronavirus defective-interfering RNA. Virology 209:428-436.
29. Lin, Y.-J., and M. M. C. Lai. 1993. Deletion mapping of a mouse hepatitis virus defective interfering RNA reveals the requirement of an internal and discontiguous sequence for replication. J. Virol. 67:6110-6118.
30. Makino, S., M.-F. Chang, C.-K. Shieh, T. Kamahora, D. M. Vannier, S. Govindarajan, and M. M. C. Lai. 1987. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature (London) 329:343-346.
31. Makino, S., N. Fujioka, and K. Fujiwara. 1985. Structure of the intracellular defective viral RNAs of defective interfering particles of mouse hepatitis virus. J. Virol. 54:329-336.
32. Makino, S., M. Joo, and J. K. Makino. 1991. A system for study of coronavirus mRNA synthesis: a regulated, expressed subgenomic defective interfering RNA results from intergenic site insertion. J. Virol. 65:6031-6041.
33. Makino, S., and M. M. C. Lai. 1989. High-frequency leader sequence switching during coronavirus defective interfering RNA replication. J. Virol. 63:5285-5292.
34. Makino, S., C.-K. Shieh, L. H. Soe, S. Baker, and M. M. C. Lai. 1988. Primary structure and translation of a defective interfering RNA of murine coronavirus. Virology 166:550-560.
35. Makino, S., L. H. Soe, C.-K. Shieh, and M. M. C. Lai. 1988. Discontinuous transcription generates heterogeneity at the leader fusion sites of coronavirus mRNAs. J. Virol. 62:3870-3873.
36. Makino, S., F. Taguchi, N. Hirano, and K. Fujiwara. 1984. Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain. Virology 139:138-151.
37. Makino, S., K. Yokomori, and M. M. C. Lai. 1990. Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J. Virol. 64:6045-6053.
38. Masters, P. S., C. A. Koetzner, C. A. Kerr, and Y. Heo. 1994. Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J. Virol. 68:328-337.
39. Pachuk, C. J., P. J. Bredenbeek, P. W. Zoltick, W. J. M. Spaan, and S. R. Weiss. 1989. Molecular cloning of the gene encoding the putative polymerase of mouse hepatitis virus, strain A59. Virology 171:141-148.
40. Repass, J. F., and S. Makino. Unpublished data.
41. Sawicki, S. G., and D. L. Sawicki. 1986. Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis. J. Virol. 57:328-334.
42. Sawicki, S. G., and D. L. Sawicki. 1990. Coronavirus transcription: subgenomic mouse hepatitis virus replicative intermediates function in RNA synthesis. J. Virol. 64:1050-1056.
43. Schaad, M. C., and R. S. Baric. 1994. Genetics of mouse hepatitis virus transcription: evidence that subgenomic negative strands are functional templates. J. Virol. 68:8169-8179.
44. Sethna, P. B., M. A. Hofmann, and D. A. Brian. 1991. Minus-strand copies of replicating coronavirus mRNAs contain antileaders. J. Virol. 65:320-325.
45. Sethna, P. B., S.-L, Hung, and D. A. Brian. 1989. Coronavirus subgenomic minus-strand RNAs and the potential for mRNA replicons. Proc. Natl. Acad. Sci. USA 86:5626-5630.
46. Shaklee, P. N. 1990. Negative-strand RNA replication by Qβ and MS positive-strand RNA phage replicases. Virology 178:340-343.
47. Spaan, W., H. Delius, M. Skinner, J. Armstrong, P. Rottier, S. Smeekens, B. A. M. van der Zeijst, and S. G. Siddell. 1983. Coronavirus mRNA synthesis involves fusion of non-contiguous sequences. EMBO J. 2:1939-1944.
48. Tousch, D., M. Jacquemond, and M. Tepfer. 1994. Replication of cucumber mosaic virus satellite RNA from negative-sense transcripts produced either in vitro or in transgenic plants. J. Gen. Virol. 75:1009-1014.
49. van der Most, R. G., P. J. Bredenbeek, and W. J. M. Spaan. 1991. A domain at the 3′ end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. J. Virol. 65:3219-3226.
50. van der Most, R. G., R. J. de Groot, and W. J. M. Spaan. 1994. Subgenomic RNA synthesis directed by a synthetic defective interfering RNA of mouse hepatitis virus: a study of coronavirus transcription initiation. J. Virol. 68:3656-3666.
51. van der Most, R. G., L. Heijnen, W. J. M. Spaan, and R. J. de Groot. 1992. Homologous RNA recombination allows efficient introduction of site-specific mutations into the genome of coronavirus MHV-A59 via synthetic co-replicating RNAs. Nucleic Acids Res. 20:3375-3381.
52. van der Werf, S., J. Bradley, E. Wimmer, F. W. Studier, and J. J. Dunn. 1986. Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83:2330-2334.
53. Weis, J. H. 1994. Race no more: an alternative approach to cloning the 5′ end of transcripts. Nucleic Acids Res. 22:3427-3428.
54. Winship, P. R. 1989. An improved method for directly sequencing PCR material using demethyl sulfoxide. Nucleic Acids Res. 17:1266.